About Manifold Biotechnologies
Manifold Biotechnologies is a private company based in Boston, Massachusetts. It has reported $78,185,480 raised in three offerings on Form D since August 2020. Its chief executive is Gleb Kuznetsov.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | Dec 3, 2024 | $32,784,801fully sold | 10 | $3.2M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 27, 2022 | Jun 13, 2022 | $39,999,985fully sold | 13 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Jul 29, 2020 | Aug 13, 2020 | $5,400,694fully sold | 6 | $900K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $78,185,480 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Manifold Biotechnologies's Form D filed Dec 3, 2024.
JB
Jory Bell
Director
GK
Gleb Kuznetsov
Chief Executive Officer and director
JH
Jeff Huber
Director
PO
Pierce Ogden
Executive officer and director
SK
Steven Kafka
Director
SH
Steven Holtzman
Director